E I Kohorn

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors
    B M Kacinski
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510
    Yale J Biol Med 62:379-92. 1989
  2. ncbi request reprint Imaging practices in the diagnosis and management of gestational trophoblastic disease: an assessment
    Ernest I Kohorn
    Trophoblast Disease Center, Department of Gynecology, Yale University School of Medicine, 333 Cedar Street, FMB 322, New Haven, CT 06510, USA
    J Reprod Med 57:207-10. 2012
  3. ncbi request reprint Presidential address. XIIIth World Congress on Gestational Trophoblastic Disease, Hong Kong, October 23-26, 2005
    Ernest I Kohorn
    Trophoblast Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    J Reprod Med 51:855-6. 2006
  4. pmc How ultrasound first came to new England
    Ernest I Kohorn
    Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Yale J Biol Med 76:155-61. 2003
  5. ncbi request reprint What we know about low-level hCG: definition, classification and management
    Ernest I Kohorn
    Yale Trophoblast Center, Department of Gynecology and Obstetrics, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    J Reprod Med 49:433-7. 2004
  6. ncbi request reprint Dynamic staging and risk factor scoring for gestational trophoblastic disease
    E I Kohorn
    Trophoblast Center, Department of Gynecology, Yale University School of Medicine, New Haven, Connecticut, USA
    Int J Gynecol Cancer 17:1124-30. 2007
  7. ncbi request reprint John McLean Morris: a career in surgery, gynecology and reproductive physiology
    Ernest I Kohorn
    Department of Gynecology, Yale University School of Medicine, New Haven, CT 06510, USA
    Conn Med 73:223-7. 2009
  8. ncbi request reprint Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report
    Ernest I Kohorn
    Department of Gynecology and Obstetrics, Yale University School of Medicine, New Haven, Connecticut, USA
    J Reprod Med 47:445-50. 2002
  9. ncbi request reprint Gestational trophoblastic neoplasia and evidence-based medicine
    Ernest I Kohorn
    Department Gynecology and Obstetrics, Yale University School of Medicine, New Haven, Connecticut, USA
    J Reprod Med 47:427-32. 2002
  10. ncbi request reprint Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma
    Ernest I Kohorn
    Department of Gynecology, Yale Trophoblast Center, Yale University School of Medicine, FMB 322, 333 Cedar Street, New Haven, CT 06510, USA
    Gynecol Oncol 85:315-20. 2002

Collaborators

Detail Information

Publications23

  1. pmc Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors
    B M Kacinski
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510
    Yale J Biol Med 62:379-92. 1989
    ..The authors discuss the role that tumor epithelial cell expression of the fms gene product might play in the auto- and paracrine control of growth and dissemination of ovarian adenocarcinomas...
  2. ncbi request reprint Imaging practices in the diagnosis and management of gestational trophoblastic disease: an assessment
    Ernest I Kohorn
    Trophoblast Disease Center, Department of Gynecology, Yale University School of Medicine, 333 Cedar Street, FMB 322, New Haven, CT 06510, USA
    J Reprod Med 57:207-10. 2012
    ..The International Society for the Study of Trophoblastic Disease should undertake carefully designed prospective studies to validate imaging practices in the management of trophoblastic disease...
  3. ncbi request reprint Presidential address. XIIIth World Congress on Gestational Trophoblastic Disease, Hong Kong, October 23-26, 2005
    Ernest I Kohorn
    Trophoblast Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    J Reprod Med 51:855-6. 2006
  4. pmc How ultrasound first came to new England
    Ernest I Kohorn
    Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Yale J Biol Med 76:155-61. 2003
    ..By then it had caught up with the pioneers in New York, Denver, and even Glasgow...
  5. ncbi request reprint What we know about low-level hCG: definition, classification and management
    Ernest I Kohorn
    Yale Trophoblast Center, Department of Gynecology and Obstetrics, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    J Reprod Med 49:433-7. 2004
    ....
  6. ncbi request reprint Dynamic staging and risk factor scoring for gestational trophoblastic disease
    E I Kohorn
    Trophoblast Center, Department of Gynecology, Yale University School of Medicine, New Haven, Connecticut, USA
    Int J Gynecol Cancer 17:1124-30. 2007
    ..A third issue is whether invasive mole should be included in the classification, as the Japanese Gynecologic Cancer Society insists is necessary. This problem may also be solved by the use of a dynamic risk factor scoring system...
  7. ncbi request reprint John McLean Morris: a career in surgery, gynecology and reproductive physiology
    Ernest I Kohorn
    Department of Gynecology, Yale University School of Medicine, New Haven, CT 06510, USA
    Conn Med 73:223-7. 2009
    ..This biographical sketch of the professional life of Dr. John McLean Morris is presented as part of the history of the Department of Obstetrics and Gynecology of Yale University School of Medicine...
  8. ncbi request reprint Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report
    Ernest I Kohorn
    Department of Gynecology and Obstetrics, Yale University School of Medicine, New Haven, Connecticut, USA
    J Reprod Med 47:445-50. 2002
    ..To discuss the current problems in establishing a unified staging and risk factor scoring system for trophoblastic disease under the auspices of the International Federation of Gynecology and Obstetrics (FIGO)...
  9. ncbi request reprint Gestational trophoblastic neoplasia and evidence-based medicine
    Ernest I Kohorn
    Department Gynecology and Obstetrics, Yale University School of Medicine, New Haven, Connecticut, USA
    J Reprod Med 47:427-32. 2002
    ..To determine whether protocols for the management of gestational trophoblastic neoplasia conform to the principles of evidence-based medicine...
  10. ncbi request reprint Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma
    Ernest I Kohorn
    Department of Gynecology, Yale Trophoblast Center, Yale University School of Medicine, FMB 322, 333 Cedar Street, New Haven, CT 06510, USA
    Gynecol Oncol 85:315-20. 2002
    ..Four cases of low-level "real" hCG are described to illustrate the problems encountered, the management, and the resolution achieved...
  11. ncbi request reprint Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?
    Ernest I Kohorn
    Yale Trophoblast Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Gynecol Oncol 85:36-9. 2002
    ..25 mg/m(2) "pulsed" actinomycin D...
  12. ncbi request reprint The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment
    E I Kohorn
    Yale Trophoblast Center, Yale University School of Medicine, New Haven, Connecticut, USA
    Int J Gynecol Cancer 11:73-7. 2001
    ..This presentation outlines the new system and provides a critical evaluation of the issues that have been resolved and those that are still outstanding...
  13. pmc The Department of Obstetrics and Gynecology at Yale: the first one hundred fifty years, from Nathan Smith to Lee Buxton
    E I Kohorn
    Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06510
    Yale J Biol Med 66:85-105. 1993
    ..Three who provided particular catalysis were Nathan Smith, Herbert Thoms, and Lee Buxton...
  14. ncbi request reprint Serum levels of macrophage colony-stimulating factor in trophoblastic disease
    E I Kohorn
    Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Gynecol Oncol 80:383-6. 2001
    ..CONCLUSION: The measurement of CSF-1 does not appear to be useful in managing trophoblastic disease as it does not correlate with the level of hCG. Occasionally, high levels of CSF-1 were found in patients with trophoblastic disease...
  15. ncbi request reprint Assessing sexual function and dyspareunia with the Female Sexual Function Index (FSFI) in women with vulvodynia
    Robin M Masheb
    Yale University School of Medicine, New Haven, Connecticut 06520 8098, USA
    J Sex Marital Ther 30:315-24. 2004
    ..Results highlight difficulties experienced across all domains of sexual function, particularly with regard to dyspareunia, for women with vulvodynia. Findings also support the internal consistency and discriminant validity of the FSFI...
  16. ncbi request reprint The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers
    Laurence A Cole
    USA hCG Reference Service, Department of Obstetrics and Gynecology, University of New Mexico Health Science Center, Albuquerque, New Mexico 87131, USA
    J Reprod Med 51:793-811. 2006
    ....
  17. ncbi request reprint Pharmacokinetic and phase I trial of intraperitoneal carboplatin and cyclosporine in refractory ovarian cancer patients
    S K Chambers
    Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06520 8063, USA
    J Clin Oncol 15:1945-52. 1997
    ..This report provides the groundwork for future studies using IP CsA, both as a chemomodulator of platinum and of multidrug resistance...
  18. ncbi request reprint Evolution of the human brain, chorionic gonadotropin and hemochorial implantation of the placenta: insights into origins of pregnancy failures, preeclampsia and choriocarcinoma
    Laurence A Cole
    USA hCG Reference Service and Division of Women s Health, Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque 87131, USA
    J Reprod Med 53:549-57. 2008
    ..It is also of note that human CG-H drives invasion by gestational trophoblastic neoplasms that have been described only in humans...
  19. ncbi request reprint Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG
    Laurence A Cole
    Department of Obstetrics and Gynecology, MSC10 5580 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
    Gynecol Oncol 102:145-50. 2006
    ..We investigated the biological function of hCG-H in invasion in vitro and in vivo and the use of hCG-H antibodies in blocking tumorigenesis and cancer growth in vivo...
  20. ncbi request reprint Problems with nomenclature and pharmacodynamics in trophoblastic disease
    Ernest I Kohorn
    J Clin Oncol 22:203-4; author reply 204. 2004
  21. ncbi request reprint Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation
    Ernest I Kohorn
    Obstet Gynecol 102:1417. 2003
  22. ncbi request reprint Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia
    Laurence A Cole
    USA hCG Reference Service, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA
    Gynecol Oncol 102:151-9. 2006
    ....
  23. ncbi request reprint A survey of the complications of vaginal prolapse surgery performed by members of the Society Of Gynecologic Surgeons
    Stephen B Young
    Division of Urogynecology and Reconstructive Pelvic Surgery, UMass Memorial Medical Center, University of Massachusetts Medical School, 119 Belmont Street, Worcester, MA 01605, USA
    Int Urogynecol J Pelvic Floor Dysfunct 15:165-70. 2004
    ..OR time was significantly shorter for HUS than SSF. The highest EBL was with SSF. Only 14% of the SGS membership responded, despite multiple requests for participation, demonstrating the difficulty of multicenter data gathering...